Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derivedno prior Q4 2015 on file Net Income-$1.23M-$1.23Mderivedno prior Q4 2015 on file EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$642,658N/M Operating Cash Flowderived-$819,850— ended Dec 31, 2016 · filed Mar 31, 2017 · 90 d after period end